KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) Invested Capital (2016 - 2026)

Evolent Health has reported Invested Capital over the past 12 years, most recently at $415.2 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 64.6% year-over-year to $415.2 million; the TTM value through Dec 2025 reached $415.2 million, down 64.6%, while the annual FY2025 figure was $415.2 million, 64.6% down from the prior year.
  • Invested Capital for Q4 2025 was $415.2 million at Evolent Health, down from $847.4 million in the prior quarter.
  • Over five years, Invested Capital peaked at $1.2 billion in Q4 2024 and troughed at $415.2 million in Q4 2025.
  • A 5-year average of $884.2 million and a median of $949.1 million in 2022 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: skyrocketed 83.53% in 2023 and later plummeted 64.6% in 2025.
  • Year by year, Invested Capital stood at $693.6 million in 2021, then grew by 23.9% to $859.4 million in 2022, then grew by 24.24% to $1.1 billion in 2023, then rose by 9.84% to $1.2 billion in 2024, then plummeted by 64.6% to $415.2 million in 2025.
  • Business Quant data shows Invested Capital for EVH at $415.2 million in Q4 2025, $847.4 million in Q3 2025, and $1.1 billion in Q2 2025.